CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

This week in charts: China deals, stock flatlines and Lilly’s M&A spree

Neutral
AI Analysis

Summary

Lilly has outpaced other pharmaceutical companies in dealmaking activity this year, while deals with Chinese drugmakers continue at a steady pace. Two mid-cap biotechs experienced stock price declines during the week.

Importance:3/10
Sentiment:
0.00
M&AChina partnershipsstock performancedealmaking
Related Companies

Read the original article

Published by BioPharma Dive on September 4, 2026 3:56 PM

Read Original